Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Home > Investor Relations > Press Releases

Press ReleasesSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

All Releases
View Summary Spectrum Pharmaceuticals Announces Second Quarter 2014 Financial Results Teleconference and Webcast
Jul 31, 2014
PDF 59.9 KB Add to Briefcase
View Summary FDA Grants Spectrum Pharmaceuticals Accelerated Approval of Beleodaq™ (belinostat) for Injection
Jul 7, 2014
PDF 71.2 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies Global Healthcare Conference in New York City on June 3rd
May 30, 2014
PDF 58.5 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Completes Enrollment in Phase 2 Trial of SPI-2012 - A Novel Long-Acting Granulocyte Colony Stimulating Factor (GCSF) to Treat Chemotherapy-induced Neutropenia
May 28, 2014
PDF 60.3 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals to Present Corporate Update at the Bank of America Merrill Lynch 2014 Health Care Conference in Las Vegas on May 13th
May 9, 2014
PDF 58.6 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Reports Financial Results for First Quarter 2014
May 8, 2014
PDF 104.2 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Announces First Quarter 2014 Financial Results Teleconference and Webcast
May 1, 2014
PDF 59.6 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals' Pivotal Trial of Captisol-Enabled™ (Propylene Glycol-Free) Melphalan Meets Primary Endpoint
Apr 23, 2014
PDF 61.2 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Promotes and Appoints Joseph Turgeon as President and Chief Operating Officer
Apr 21, 2014
PDF 75.1 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals to Present Corporate Update at the 26th Annual ROTH Conference in Laguna Niguel on March 11th
Mar 7, 2014
PDF 58.5 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Reports Fourth and Full Year 2013 Financial Results
Mar 6, 2014
PDF 115.1 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Announces Fourth Quarter 2013 Financial Results Teleconference and Webcast
Feb 27, 2014
PDF 59.6 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Announces FDA's Acceptance of NDA Filing for Beleodaq™ (belinostat) for Injection, a novel pan-HDAC inhibitor
Feb 6, 2014
PDF 15.6 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference in San Francisco on January 16th
Jan 9, 2014
PDF 58.6 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Announces Pricing of $100 Million Convertible Notes Offering
Dec 18, 2013
PDF 14.5 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Announces Offering of $100 Million of Convertible Notes
Dec 16, 2013
PDF 13.9 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Highlights Encouraging FOLOTYN® and MARQIBO® Clinical Data Presented at the 55th Annual Meeting of the American Society of Hematology (ASH)
Dec 11, 2013
PDF 79.3 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Announces Submission of New Drug Application for Belinostat, a novel pan-HDAC inhibitor
Dec 10, 2013
PDF 15.4 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Highlights 13 Abstracts at the 55th Annual Meeting of the American Society of Hematology (ASH), New Orleans, Louisiana, December 7-10, 2013
Dec 6, 2013
PDF 90.7 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Reports Financial Results for Third Quarter 2013
Nov 12, 2013
PDF 110.5 KB Add to Briefcase
Showing 1-20 of 626 Page: 1 2 3 4 5 ... 32  Next 20
Add to Briefcase = add release to Briefcase

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

NASDAQ: SPPISpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Price:
7.04
Change:
- 0.16
Day High:
7.17
Day Low:
6.94
Volume:
678,900
4:00 PM ET on Jul 31, 2014
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder ToolsSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Print Email

Search IRSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company